The bile salt-stimulated cholesterol esterase is a digestive enzyme synthesized by the acinar cells of the pancreas. Previous results have shown that cholesterol esterase biosynthesis and secretion in the AR42J pancreatoma cells could be increased 3-5-fold by intestinal hormones such as cholecystokinin (CCK). The purpose of the current study is to explore the signalling mechanism by which CCK stimulation of AR42J cells results in increased biosynthesis and secretion of the cholesterol esterase. The results showed that the CCK-induced cholesterol esterase secretion could be mimicked by addition of the Ca2l ionophore A23 187 or by transient incubation of AR42J cells with the protein kinase C
INTRODUCTION
Intestinal hormones are produced in vivo in response to different nutrients present in the gut [1] . For example, secretin is produced in response to fat consumption while cholecystokinin (CCK) is released from intestinal cells in response to increased protein influx. The effects of these hormones in the regulation of digestive enzyme biosynthesis can be studied using the rat pancreatoma cell line AR42J. This cell line is a viable model for studying the acute response of pancreatic acinar cells to hormonal stimulation due to its production of amylase, chymotrypsin, lipase and trypsinogen [2] . Moreover, the AR42J cells have been shown to possess hormone receptors similar to those found in normal rat pancreatic acini [3] .
Previously, CCK was reported to stimulate amylase and chymotrypsinogen biosynthesis in AR42J cells [4, 5] . The amylase and chymotrypsin mRNA isolated from hormone-stimulated AR42J cells were translated more efficiently than those obtained from unstimulated cells [4] , thus suggesting a post-transcriptional regulatory mechanism. Using the AR42J cells as a model to study hormonal regulation of cholesterol esterase biosynthesis, our laboratory has reported that cholesterol esterase biosynthesis could be increased by either secretin, CCK or bombesin stimulation of the AR42J cells [6, 7] . The hormone-induced cholesterol esterase biosynthesis was shown to be mediated by activation of a post-transcriptional event, probably the increased translation of cholesterol esterase mRNA [6] .
The exact mechanism by which CCK and secretin activate cholesterol esterase biosynthesis remains unknown. However, the initial event for hormone-induced pancreatic functions is the binding of the hormone to receptors on the cell membrane [8, 9] . Hormone-receptor interactions trigger a series of signal transactivator phorbol 1 2-myristate 13-acetate (PMA). Cholesterol esterase stimulation by CCK, A23 187 and PMA could be abolished by the calcium chelator BAPTA or by specific protein kinase C inhibitors such as chelerythrine. Additionally, prolonged incubation of AR42J cells with PMA to reduce the protein kinase C level, also reduced CCK-stimulated cholesterol esterase secretion to a level similar to that observed in control cells. Taken together, these data suggested that CCK activation of cholesterol esterase secretion may be mediated by a Ca2+-dependent protein kinase C pathway, requiring increases in calcium mobilization and activation of protein kinase C. duction pathways leading to the production of physiological responses. For example, secretin binding to the secretin receptor results in adenylate cyclase stimulation and an increased level of cyclic AMP [10] . The elevated level of cyclic AMP activates protein kinase A, which then phosphorylates specific proteins that may be involved with digestive enzyme synthesis and secretion [11] . In contrast, the binding of CCK, a cholinergic agent, to its receptor on pancreatic cell surfaces results in the activation of signal-transduction mediated by G-proteins [12, 13] . The G-proteins activate phospholipase C-catalysed hydrolysis of phosphatidylinositol-4,5-bisphophate to sn-1,2-diacylglycerol (1,2-DAG) and D-inositol 1,4,5-trisphosphate. These products in turn act on other intracellular targets, leading ultimately to increased protein biosynthesis. The 1,2-DAG activates the calcium-and phospholipid-dependent protein kinase C, while the inositol trisphosphate stimulates the release of calcium from an intracellular pool (reviewed in [14] ). The increase in calcium flux may act either synergistically with protein kinase C activation [15, 16] or independent of protein kinase C [17] with the calcium chelator BAPTA abolished the ionophoreinduced cholesterol esterase secretion (Table 2) . Interestingly, the protein kinase C inhibitor chelerythrine, as well as the nonspecific protein kinase inhibitor staurosporine, also inhibited the A23187-induced cholesterol esterase secretion by AR42J cells ( Table 2 ). The role of protein kinase C activation in cholesterol esterase secretion was examined by taking advantage of the availability of the diacylglycerol analogue (PMA), which has been shown previously to modulate the activity of protein kinase C [19] . The transient preincubation of AR42J cells with PMA resulted in a 2.2-fold increase in cholesterol esterase secretion (Table 3) . This stimulation could be inhibited by preincubating the cells with either the protein kinase C-specific inhibitor chelerythrine, the non-specific kinase inhibitor staurosporine, or the calcium chelator BAPTA (Table 3) .
The role of protein kinase C in mediating CCK stimulation of cholesterol esterase secretion was explored directly by measuring the CCK stimulation of cholesterol esterase secretion after an overnight incubation of the AR42J cells with PMA. The prolonged incubation of AR42J with PMA, which reduces the protein kinase C level in tissue culture cells [14] , resulted in inhibition of CCK-activated cholesterol esterase secretion. The amount of cholesterol esterase found in the medium of CCKtreated cells after prolonged incubation with PMA was similar to that observed in the medium of unstimulated control AR42J cells (Table 4 In summary, the results of this study show that CCK-induced cholesterol esterase biosynthesis is mediated by increasing cal-cium flux and activation ofprotein kinase C-dependent pathways. In view of the putative role of cholesterol esterase in mediating dietary cholesterol absorption through the intestine [22] , these studies suggest that therapeutic modulation of pancreatic signal transduction pathways may be a potentially useful strategy in reducing cholesterol absorption efficiency, thus lowering plasma cholesterol level and reducing the risk of cardiovascular disease.
